熱門資訊> 正文
TBC医疗集团宣布2000万美元股票回购计划
2025-12-31 21:35
- SBC Medical Group (SBC) announced on Wednesday a share repurchase program and the filing of a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC).
- The company’s board of directors has authorized a $20 million share repurchase program, pursuant to which the company may repurchase shares of its common stock from time to time through open market transactions, through privately negotiated transactions, or by other means, in accordance with applicable securities laws and restrictions. The repurchase program terminates on December 31, 2026, and may be modified, suspended or discontinued at any time in the Company’s discretion.
- The company’s Form S-3 Registration Statement, which was declared effective by the SEC on December 30, 2025, enables the company to offer and sell, from time to time in one or more offerings, up to $50 million of common stock or preferred stock on a primary basis.
- The company said it is not selling any securities from the shelf registration statement at this time, and if the company decides to raise capital in a future offering using the shelf registration statement, the Company will describe the specific details of that future offering in a prospectus supplement that is filed with the SEC. The firm added that it believes that a shelf registration on Form S-3 will provide greater flexibility to raise capital in the future, to facilitate growth, including domestic and international M&A, and supports its efforts to increase its public float.
More on SBC Medical Group Holdings
- SBC Medical: Statistical Cheapness Masks Fundamental Flaws
- Seeking Alpha’s Quant Rating on SBC Medical Group Holdings
- Historical earnings data for SBC Medical Group Holdings
- Financial information for SBC Medical Group Holdings
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。